[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 71, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph Michael Redmond", "age": 62, "title": "President & Interim Principal Executive Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 9611}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 314896, "exercisedValue": 0, "unexercisedValue": 4554}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.27, "open": 1.23, "dayLow": 1.06, "dayHigh": 1.2199, "regularMarketPreviousClose": 1.27, "regularMarketOpen": 1.23, "regularMarketDayLow": 1.06, "regularMarketDayHigh": 1.2199, "beta": 0.484, "forwardPE": -0.09907408, "volume": 130297, "regularMarketVolume": 130297, "averageVolume": 601280, "averageVolume10days": 677640, "averageDailyVolume10Day": 677640, "bid": 0.7007, "ask": 0.83, "bidSize": 800, "askSize": 800, "marketCap": 5971338, "fiftyTwoWeekLow": 0.86, "fiftyTwoWeekHigh": 7.74, "priceToSalesTrailing12Months": 799.8042, "fiftyDayAverage": 1.1286, "twoHundredDayAverage": 2.41745, "currency": "USD", "enterpriseValue": 6215443, "floatShares": 5051085, "sharesOutstanding": 5580690, "sharesShort": 701412, "sharesShortPriorMonth": 71190, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.1257, "heldPercentInsiders": 0.18652001, "heldPercentInstitutions": 0.07079, "shortRatio": 0.63, "shortPercentOfFloat": 0.1389, "bookValue": -0.048, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -19516236, "trailingEps": -7.33, "forwardEps": -10.8, "lastSplitFactor": "1:10", "lastSplitDate": 1516579200, "enterpriseToRevenue": 832.5, "enterpriseToEbitda": -0.316, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "OGEN", "underlyingSymbol": "OGEN", "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "firstTradeDateEpochUtc": 1077719400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "747ffae6-a5e0-3f81-bef4-ef8201719134", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.07, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 1348621, "totalCashPerShare": 0.242, "ebitda": -19638392, "quickRatio": 0.975, "currentRatio": 1.17, "totalRevenue": 7466, "revenuePerShare": 0.002, "returnOnAssets": -2.19891, "returnOnEquity": -4.5471897, "freeCashflow": -9515050, "operatingCashflow": -7214335, "operatingMargins": -2632.8518, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-04"}]